ALPN - Alpine Immune Sciences GAAP EPS of -$0.64 revenue of $58.88M
2024-03-18 16:15:47 ET
More on Alpine Immune Sciences
- Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug
- Alpine Immune Looks Highly Interesting Except For The Price (Rating Upgrade)
- Alpine Immune Sciences Q4 2023 Earnings Preview
- Wolfe starts Alpine Immune at outperform, cites upcoming catalysts
- Seeking Alpha’s Quant Rating on Alpine Immune Sciences